Literature DB >> 21309059

Independent and combined associations of abdominal obesity and seated resting heart rate with type 2 diabetes among older Chinese: the Guangzhou Biobank Cohort Study.

Bríain ó Hartaigh1, Chao Qiang Jiang, Jos A Bosch, Wei Sen Zhang, Kar Keung Cheng, Tai Hing Lam, G Neil Thomas.   

Abstract

BACKGROUND: Central obesity and poor physical fitness predict the development of type 2 diabetes and cardiovascular mortality among Caucasian populations. We studied the independent and combined effect of abdominal obesity and seated resting heart rate used as an indicator of physical fitness, on the presence of type 2 diabetes among 30 519 older residents of Guangzhou, Southern China.
METHODS: Participants were stratified into four groups, based on the Asian criteria for abdominal obesity (≥90/≥ 80 cm in men/women) and the 75% cut-off point for seated resting heart rate (≥83 beats per min). The association with type 2 diabetes was assessed using multivariable logistic regression.
RESULTS: A total of 3777 (12.7%) volunteers were diagnosed with type 2 diabetes, which was independently associated with seated resting heart rate and, in particular, increasing levels of abdominal obesity (p < 0.001). An odds ratio of 3.93 (95% confidence interval = 3.48-4.43) was identified for type 2 diabetes in participants who were obese with a seated resting heart rate ≥ 83 beats per min after adjusting for potential confounders.
CONCLUSIONS: Higher seated resting heart rate, a marker of poor physical fitness, independently doubles the risk of type 2 diabetes. The strength of this association is further increased when abdominal obesity is considered.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21309059     DOI: 10.1002/dmrr.1178

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  7 in total

1.  Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study.

Authors:  Liang Wang; Liufu Cui; Yanxue Wang; Anand Vaidya; Shuohua Chen; Caifeng Zhang; Ying Zhu; Dongqing Li; Frank B Hu; Shouling Wu; Xiang Gao
Journal:  Int J Epidemiol       Date:  2015-05-22       Impact factor: 7.196

Review 2.  Current lifestyle factors that increase risk of T2DM in China.

Authors:  N Zhang; S M Du; G S Ma
Journal:  Eur J Clin Nutr       Date:  2017-04-19       Impact factor: 4.016

3.  Prevalence of obesity among students aged 6 to 12 in China: a meta-analysis.

Authors:  Yue Tian; Haixia Wu
Journal:  Food Nutr Res       Date:  2015-12-17       Impact factor: 3.894

4.  PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights.

Authors:  Yap-Hang Chan; Jo Jo Hai; Kui-Kai Lau; Sheung-Wai Li; Chu-Pak Lau; Chung-Wah Siu; Kai-Hang Yiu; Hung-Fat Tse
Journal:  BMC Cardiovasc Disord       Date:  2017-08-24       Impact factor: 2.298

5.  Independent and cumulative effects of resting heart rate and pulse pressure with type 2 diabetes mellitus in Chinese rural population.

Authors:  Panpan Wang; Yuqian Li; Xiaotian Liu; Quanxin Wang; Ying Guo; Yang Zhao; Linlin Li; Jingjing Fan; Hao Zhou; Zhenxing Mao; Gongyuan Zhang; Chongjian Wang
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

6.  Epidemiology of Isolated Impaired Glucose Tolerance Among Adults Aged Above 50 Years in Rural China.

Authors:  Xiaobing Tian; Yan Li; Jie Liu; Qiuxing Lin; Qiaoxia Yang; Jun Tu; Jinghua Wang; Jidong Li; Xianjia Ning
Journal:  Diabetes Metab Syndr Obes       Date:  2021-09-16       Impact factor: 3.168

7.  The combination of cardiorespiratory fitness and muscular fitness, and prevalence of diabetes mellitus in middle-aged and older men: WASEDA'S Health Study.

Authors:  Dong Wang; Susumu S Sawada; Hiroki Tabata; Ryoko Kawakami; Tomoko Ito; Kumpei Tanisawa; Mitsuru Higuchi; Kaori Ishii; Koichiro Oka; Katsuhiko Suzuki; Shizuo Sakamoto
Journal:  BMC Public Health       Date:  2022-03-30       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.